ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure
Published on 08/07/2025 at 18:04 |
prnewswire.co.uk
ARTBIO Denmark Finland France Germany Netherlands Sweden United Kingdom Norway Massachusetts